BRAF and melanoma: Many melanomas carry gain-of-function mutations in the v-RAF murine sarcoma viral oncogene homolog B1 (BRAF), which functions in cell division and differentiation and is treatable with a BRAF inhibitor (BRAFi) in these cases (Meng et al. 2015).